"
Team:BIOSINT Mexico/operations
From 2012e.igem.org
(Difference between revisions)
| (8 intermediate revisions not shown) | |||
| Line 131: | Line 131: | ||
</div> | </div> | ||
<p>Kuxtal Biotech is going to be installed in Queretaro City, in the Industrial Park Benito Juárez, which is located in Av. 5 de febrero No. 1057, CP. 76130 (geographical coordinates: 20°37'40" N and 100°25'46" W and 1890 m above sea level).</br></br>The climate in the region is tempered and semi-dry, with a maximum temperature of 35.2 ° C and minimum of 1.8 ° C, with an annual average of 17 °C.</br></br> | <p>Kuxtal Biotech is going to be installed in Queretaro City, in the Industrial Park Benito Juárez, which is located in Av. 5 de febrero No. 1057, CP. 76130 (geographical coordinates: 20°37'40" N and 100°25'46" W and 1890 m above sea level).</br></br>The climate in the region is tempered and semi-dry, with a maximum temperature of 35.2 ° C and minimum of 1.8 ° C, with an annual average of 17 °C.</br></br> | ||
| - | The construction is 200 m2 and the cost of the rent is 808 USD, it has offices | + | The construction is 200 m2 and the cost of the rent is 808 USD, it has offices within an area of 29m2, an access ramp and parking space for 4. The interior design includes: slab floor with epoxy paste, masonry walls covered with plaster and vinyl coatings.</br></br> |
<div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/Operational Plan Infrastructure.png" alt="Opereational plan" /></div> | <div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/Operational Plan Infrastructure.png" alt="Opereational plan" /></div> | ||
</p> | </p> | ||
| Line 142: | Line 142: | ||
<p class="clr-1"><strong>Operative cycle.</strong></p> | <p class="clr-1"><strong>Operative cycle.</strong></p> | ||
</div> | </div> | ||
| - | <p> | + | <p><div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/OPP.png"/></div></p> |
</div> | </div> | ||
| Line 152: | Line 152: | ||
<p class="clr-1"><strong>Installed capacity.</strong></p> | <p class="clr-1"><strong>Installed capacity.</strong></p> | ||
</div> | </div> | ||
| - | <p> | + | <p>The daily production capacity analysis by equipment is presented below:</br></br> |
| - | The daily production capacity analysis by equipment is presented below:</br></br> | + | With the Applied Biosystems ABI 394 DNA Synthesizer Kuxtal Biotech will be able to extend two or four oligonucleotides simultaneously at a rate of 12 bases per hour.</br></br></br> |
| - | With the Applied Biosystems ABI 394 DNA Synthesizer Kuxtal Biotech will be able to extend two or four oligonucleotides simultaneously at a rate of 12 bases per hour.</br></br> | + | |
| - | <div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/ | + | <div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/OP2.png"></div> |
| - | + | ||
| - | Total capacity: | + | Total capacity: 7.2 mers/hour x 24 hours/day = 172.8 bases /day x 4 ABI 394 DNA Synthesizer = 32 primers produced per day.</br></br> |
| - | + | </p> | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
</div> | </div> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
</div> | </div> | ||
| Line 189: | Line 167: | ||
<p class="clr-1"><strong>Quality assurance systems.</strong></p> | <p class="clr-1"><strong>Quality assurance systems.</strong></p> | ||
</div> | </div> | ||
| - | <p>Kuxtal Biotech is looking for certifications like ISO 9001:2008 to ensure the quality of its management system and demonstrate its ability to consistently provide products or services that meet customer requirements; it also seeks continuous improvement | + | <p>Kuxtal Biotech is looking for certifications like ISO 9001:2008 to ensure the quality of its management system and demonstrate its ability to consistently provide products or services that meet customer requirements; it also seeks continuous improvement, legal assurance and regulatory requirements. Among the technical requirements Kuxtal seeks to achieve the evaluation of personnel, facilities and environmental conditions, method validation, maintenance and calibration of equipment, quality of materials and reagents, quality assurance of results and its reporting. |
</p> | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
| - | |||
</div> | </div> | ||
Latest revision as of 01:34, 28 October 2012
WHAT I CANNOT CREATE, I DO NOT UNDERSTAND RICHARD FEYNMAN’S
Operations Plan
Location and infrastructure.
Kuxtal Biotech is going to be installed in Queretaro City, in the Industrial Park Benito Juárez, which is located in Av. 5 de febrero No. 1057, CP. 76130 (geographical coordinates: 20°37'40" N and 100°25'46" W and 1890 m above sea level).The climate in the region is tempered and semi-dry, with a maximum temperature of 35.2 ° C and minimum of 1.8 ° C, with an annual average of 17 °C. The construction is 200 m2 and the cost of the rent is 808 USD, it has offices within an area of 29m2, an access ramp and parking space for 4. The interior design includes: slab floor with epoxy paste, masonry walls covered with plaster and vinyl coatings.
Operative cycle.
Installed capacity.
The daily production capacity analysis by equipment is presented below: With the Applied Biosystems ABI 394 DNA Synthesizer Kuxtal Biotech will be able to extend two or four oligonucleotides simultaneously at a rate of 12 bases per hour.
Quality assurance systems.
Kuxtal Biotech is looking for certifications like ISO 9001:2008 to ensure the quality of its management system and demonstrate its ability to consistently provide products or services that meet customer requirements; it also seeks continuous improvement, legal assurance and regulatory requirements. Among the technical requirements Kuxtal seeks to achieve the evaluation of personnel, facilities and environmental conditions, method validation, maintenance and calibration of equipment, quality of materials and reagents, quality assurance of results and its reporting.
